Other Events ·
At its 2026 Annual Meeting of Shareholders held on June 9, 2026, OptimizeRx Corporation shareholders approved an…
OPRXOptimizeRx Corp
At its 2026 Annual Meeting of Shareholders held on June 9, 2026, OptimizeRx Corporation shareholders approved an amendment to the 2021 Equity Incentive Plan to increase the available common stock for awards by 1,000,000 shares, bringing the total to 5,450,000 shares. Shareholders also elected seven directors, approved advisory executive compensation, and ratified Grant Thornton, LLP as the independent auditor for the 2026 fiscal year. However, a proposal to adopt an evergreen provision for automatic annual increases to the Equity Plan was rejected. OptimizeRx Corporation is a healthcare technology company providing commercialization solutions.